NRSN NeuroSense Therapeutics Ltd Buxgalteriya kapitallashuvi

Ommaviy kompaniya NeuroSense Therapeutics, Ltd. (NRSN) logotipi

NeuroSense Therapeutics (NRSN) qat'iy huquqiy muvofiqlik va grantlar hisobotidagi shaffoflikka ustuvorlik beruvchi amaliyotchi-olimlar tomonidan boshqariladi. GURU.Markets platformasidagi ushbu kunlik narxlar grafigi mazkur yondashuvni vizuallashtiradi va joriy ko'rsatkich 0.00 darajasida turibdi. Kompaniya o'z laboratoriyalarida yashil texnologiyalarni joriy qilmoqda va uning o'sishi neyropreparatlar bo'yicha istiqbolli tadqiqotlar bilan ta'minlanmoqda, garchi u hali barqaror operatsion daromadga erishmagan bo'lsa-da.

NRSN NeuroSense Therapeutics, Ltd. Balans kapitallashuvi (04.07.2022 - 27.10.2026)

NeuroSense Therapeutics, Ltd. (NRSN) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Birja grafigi NeuroSense Therapeutics|NRSN - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi NeuroSense Therapeutics Ltd|NRSN - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga xususiy kapital NeuroSense Therapeutics|NRSN - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti neurosense-tx.com|NRSN - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati NeuroSense Therapeutics|NRSN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati NeuroSense Therapeutics|NRSN - Kompaniya qarzlari|Balans qiymatiga qarzlar NeuroSense Therapeutics Ltd
Kompaniyaning jamlanma tahlili:NeuroSense Therapeutics Ltd. - NRSN
neurosense-tx.com yetakchi tovari

Balans qiymati barcha majburiyatlar ayirilgandan keyingi sof aktivlar qiymatini aks ettirib, biznesning real aktivlar bazasining o'lchovi bo'lib xizmat qiladi. Neyrodegeneratsiyaga qarshi murakkab ishlanmalarga investitsiya kiritayotgan NeuroSense Therapeutics (NRSN) uchun balans qiymati darajasi kompaniyaning ilmiy tadqiqotlarni o'z resurslari hisobidan moliyalashtirish qobiliyatini namoyish etadi va operatsion daromadlar yo'qligida moliyaviy barqarorlikni tasdiqlaydi.

Asosiy raqobatchilar

BIIB: Biznesning balans bahosi|Kompaniyaning balans qiymati Neurocrine Biosciences|RGC (regencellbioscience.com) - Buxgalteriya kapitallashuvi|Kompaniyaning balans qiymati Axsome Therapeutics, Inc. (AXSM)|Buxgalteriya kapitallashuvi ACADIA Pharma|Xenon Pharmaceuticals Inc - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Viking Therapeutics Corp VKTX|Kompaniyaning sof aktivlari SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Denali Therapeutics Inc. (DNLI)|HRMY: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati BHVN|AMLX (Amylyx Corp) - Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati Trevi Therapeutics (TRVI)|Buxgalteriya kapitallashuvi praxismedicines.com|Anavex Life Sciences Corp. - Balans kapitallashuvi|Kompaniyaning xususiy kapitali CeriBell Inc CBLL|Kompaniyaning sof aktivlari PRTA (prothena.com)|Alector Inc. - Balans kapitallashuvi|Kompaniyaning balans qiymati Annexon, Inc. (ANNX)|OMER: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati NGNE|ACIU (AC Immune S.A.) - Kompaniyaning xususiy kapitali|VYGR: Kompaniyaning balans qiymati|Biznesning balans bahosi Neumora Corp|Scilex Holding Company - Balans kapitallashuvi|Kompaniyaning xususiy kapitali TVGN (tevogen.com)|ACOG - Kompaniyaning balans qiymati|cogrx.com - Buxgalteriya kapitallashuvi|Kompaniyaning balans qiymati IKT (Inhibikase)|SAVA - Biznesning balans bahosi|Balans kapitallashuvi ASRT|Kompaniyaning xususiy kapitali Coya Therapeutics|VTGN - Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati Ovid Rx (OVID)|Kompaniyaning sof aktivlari Acumen Pharma|Jami sof aktivlar CervoMed Corporation (CRVO)|Balans kapitallashuvi Alterity Therapeutics Limited|Kompaniyaning buxgalteriya qiymati Clene Inc CLNN|PEPG (PepGen Corp) - Balans kapitallashuvi|JUNS: Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati Relmada RLMD|Annovis Bio Corporation (ANVS) - Kompaniyaning buxgalteriya qiymati|GRCE (Grace Therapeutics Inc) - Balans kapitallashuvi|Balans kapitallashuvi AIFF|KLTO - Kompaniyaning balans qiymati|Sof aktivlar qiymati Reviva Pharmaceuticals Holdings Inc. (RVPH)|MTVA: Balans kapitallashuvi|NRXS - Kompaniyaning xususiy kapitali|Helius Medical Technologies Inc. - Kompaniyaning sof aktivlari|Passage Bio, Inc. (PASG) - Balans kapitallashuvi|NEUP - Kompaniyaning sof aktivlari|Minerva Neurosciences Inc (NERV) - Jami sof aktivlar|ATHA: Balans kapitallashuvi|Biznesning balans bahosi Addex|Balans kapitallashuvi ALZN (Alzamend Neuro, Inc.)|Kompaniyaning sof aktivlari CYCN (cyclerion.com)|Kompaniyaning balans qiymati PTIX|Pasithea Therapeutics Corp - Biznesning balans bahosi|Cortigent Medical (CRGT) - Kompaniyaning balans qiymati|ATXI: Buxgalteriya kapitallashuvi|Kompaniyaning balans qiymati Brainstorm Cell BCLI|CARA (caratherapeutics.com) - Kompaniyaning buxgalteriya qiymati|CHRO: Kompaniyaning balans qiymati|Biznesning balans bahosi ELYM|Kompaniyaning balans qiymati Intra-Cellular Therapies ITCI|Buxgalteriya kapitallashuvi LBPH (Longboard)|MRNS - Kompaniyaning balans qiymati|Buxgalteriya kapitallashuvi nkgenbiotech.com NKGN|NRBO (NeuroBo Pharmaceuticals, Inc.) - Balans kapitallashuvi|Sage Therapeutics Inc. (SAGE) - Kompaniyaning xususiy kapitali|SNPX: Kompaniyaning sof aktivlari|TRVN (Trevena Inc) - Balans kapitallashuvi|VIGL - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati WENA|Cerevel Therapeutics, Inc. - Kompaniyaning balans qiymati